nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ORM1—saliva—nicotine dependence	0.306	0.49	CbGeAlD
Penbutolol—HTR1B—cardiovascular system—nicotine dependence	0.0578	0.0926	CbGeAlD
Penbutolol—ADRB1—cardiovascular system—nicotine dependence	0.0544	0.0871	CbGeAlD
Penbutolol—HTR1A—cardiovascular system—nicotine dependence	0.0467	0.0747	CbGeAlD
Penbutolol—HTR1B—midbrain—nicotine dependence	0.0452	0.0723	CbGeAlD
Penbutolol—HTR1A—midbrain—nicotine dependence	0.0365	0.0584	CbGeAlD
Penbutolol—HTR1B—brain—nicotine dependence	0.0284	0.0454	CbGeAlD
Penbutolol—ADRB1—brain—nicotine dependence	0.0267	0.0428	CbGeAlD
Penbutolol—HTR1A—brain—nicotine dependence	0.0229	0.0367	CbGeAlD
Penbutolol—Disorientation—Varenicline—nicotine dependence	0.0157	0.0968	CcSEcCtD
Penbutolol—Amnesia—Varenicline—nicotine dependence	0.015	0.0922	CcSEcCtD
Penbutolol—Affect lability—Varenicline—nicotine dependence	0.0138	0.0853	CcSEcCtD
Penbutolol—Mood swings—Varenicline—nicotine dependence	0.0133	0.0821	CcSEcCtD
Penbutolol—Erectile dysfunction—Varenicline—nicotine dependence	0.0112	0.0689	CcSEcCtD
Penbutolol—Depression—Varenicline—nicotine dependence	0.0108	0.0666	CcSEcCtD
Penbutolol—HTR1B—Monoamine GPCRs—DRD2—nicotine dependence	0.0107	0.0502	CbGpPWpGaD
Penbutolol—Bradycardia—Varenicline—nicotine dependence	0.00991	0.061	CcSEcCtD
Penbutolol—HTR1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00898	0.0422	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00851	0.04	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—DRD2—nicotine dependence	0.00833	0.0391	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00814	0.0382	CbGpPWpGaD
Penbutolol—Cough—Varenicline—nicotine dependence	0.00739	0.0455	CcSEcCtD
Penbutolol—HTR1B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00729	0.0342	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00715	0.0336	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.007	0.0329	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00684	0.0321	CbGpPWpGaD
Penbutolol—Hyperhidrosis—Varenicline—nicotine dependence	0.00668	0.0412	CcSEcCtD
Penbutolol—Insomnia—Varenicline—nicotine dependence	0.00625	0.0385	CcSEcCtD
Penbutolol—Dyspnoea—Varenicline—nicotine dependence	0.00616	0.038	CcSEcCtD
Penbutolol—Dyspepsia—Varenicline—nicotine dependence	0.00609	0.0375	CcSEcCtD
Penbutolol—Fatigue—Varenicline—nicotine dependence	0.00596	0.0367	CcSEcCtD
Penbutolol—Pain—Varenicline—nicotine dependence	0.00591	0.0364	CcSEcCtD
Penbutolol—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00555	0.0261	CbGpPWpGaD
Penbutolol—Body temperature increased—Varenicline—nicotine dependence	0.00547	0.0337	CcSEcCtD
Penbutolol—Asthenia—Varenicline—nicotine dependence	0.00496	0.0305	CcSEcCtD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00476	0.0224	CbGpPWpGaD
Penbutolol—Diarrhoea—Varenicline—nicotine dependence	0.00473	0.0291	CcSEcCtD
Penbutolol—Dizziness—Varenicline—nicotine dependence	0.00457	0.0282	CcSEcCtD
Penbutolol—HTR1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00441	0.0207	CbGpPWpGaD
Penbutolol—Headache—Varenicline—nicotine dependence	0.00433	0.0267	CcSEcCtD
Penbutolol—Nausea—Varenicline—nicotine dependence	0.00411	0.0253	CcSEcCtD
Penbutolol—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00352	0.0165	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00344	0.0161	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00336	0.0158	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00318	0.0149	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00307	0.0144	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00289	0.0135	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00285	0.0134	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00249	0.0117	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00244	0.0115	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00234	0.011	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00227	0.0107	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00227	0.0106	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00222	0.0104	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00222	0.0104	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00217	0.0102	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00206	0.00968	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00199	0.00933	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.00196	0.00919	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00195	0.00914	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00194	0.00913	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0019	0.00894	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0019	0.00892	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00186	0.00874	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00186	0.00874	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0018	0.00847	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.00178	0.00835	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00177	0.0083	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00177	0.00829	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00173	0.0081	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00169	0.00795	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00164	0.00771	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00161	0.00754	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00157	0.00738	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.00156	0.00732	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.00153	0.00716	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00149	0.007	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.00148	0.00696	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.00145	0.00681	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.00142	0.00666	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.00142	0.00665	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00141	0.00661	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.00139	0.0065	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00138	0.00646	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.00135	0.00636	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00135	0.00632	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.00135	0.00632	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.00134	0.00628	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.00107	0.00503	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.00107	0.005	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00105	0.00494	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.00105	0.00493	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.00105	0.00492	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.00104	0.0049	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.00103	0.00481	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00102	0.00479	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000955	0.00448	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000928	0.00436	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000838	0.00393	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000836	0.00393	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000819	0.00385	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.000818	0.00384	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000801	0.00376	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.0008	0.00376	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000761	0.00357	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	0.00076	0.00357	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000744	0.00349	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000739	0.00347	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000728	0.00342	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000723	0.00339	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000707	0.00332	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	0.000691	0.00324	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—WASF2—nicotine dependence	0.000654	0.00307	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—WASF1—nicotine dependence	0.000627	0.00294	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.000606	0.00284	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000592	0.00278	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000579	0.00272	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000564	0.00265	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.00055	0.00258	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.000538	0.00253	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	0.000526	0.00247	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000521	0.00244	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000509	0.00239	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.000499	0.00234	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—WASF2—nicotine dependence	0.000498	0.00234	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.000488	0.00229	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—WASF1—nicotine dependence	0.000477	0.00224	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000449	0.00211	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.00044	0.00206	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	0.00043	0.00202	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—DRD2—nicotine dependence	0.000408	0.00192	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—DRD2—nicotine dependence	0.000325	0.00153	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—DRD2—nicotine dependence	0.000318	0.00149	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD2—nicotine dependence	0.000311	0.00146	CbGpPWpGaD
